Objectives: Low back pain (LBP) is common, but sufferers pursue a range of management options and only some seek professional advice. This study examines how Australian consumers report that they manage LBP, with emphasis on the extent to which their practices match clinical recommendations and guidelines.
L ow back pain (LBP) is defined as pain and discomfort, localized below the costal margin and above the inferior gluteal folds, with or without leg pain. 1 LBP can occur in isolation or together with somatic referred pain into the lower limbs. 2 Acute LBP rarely has a serious cause, is usually self-limiting, and the majority of patients will recover with the use of simple analgesics and advice to keep active. 3 LBP is common; 4 out of 5 Australian adults will experience LBP at some point during their life. 4 Although only a small proportion (B5%) of people with acute LBP develops chronic LBP (duration >12 wk), recurrences are common. 5 The cumulative risk of at least 1 recurrence of LBP within 12 months has been reported to vary from 66% to 84% (pooled estimate 73%, 59%-88%). 6 Recent Australian research found that 76% of the patients with LBP had had an earlier episode. 7 Despite these high recurrence rates, it has been suggested that with good management, recurrence rates could be less than 25%. 2 As the first line of care, treatment guidelines for acute LBP recommend the provision of patient advice to remain active, avoid bed rest, reassurance of favorable prognosis, and the use of regular simple analgesics. 1, 8 In acute LBP, paracetamol (4 g/d) is the preferred first choice of analgesic, based on evidence of its effectiveness and its low risk of qside effects and drug interactions. 1 There is moderate evidence that paracetamol is as effective as nonsteroidal antiinflammatory drugs (NSAIDs) in this setting. [9] [10] [11] In contrast to acute LBP, few management guidelines for chronic LBP are available. 12 Those that are available offer somewhat conflicting advice. European Guidelines strongly recommend the short-term use of NSAIDs and weak opioid analgesics, 12 whereas guidelines in the United States recommend the use of either paracetamol or an NSAID (short term) after consideration of the risks and benefits of each product in the individual patient, 13 and those from Australia recommend paracetamol as first line with a short course of NSAIDs being reserved for second line therapy in chronic LBP. 14 In this study, we investigated how Australian consumers with either first-time or recurrent LBP report that they manage their condition with a focus on self-management strategy, level of activity, and choice of analgesic. Through a greater understanding of consumer actions, we aimed to gain insight into some of the reasons for the high recurrence rates of LBP.
METHODS

Patient Population
Eligible participants were men and women >18 years of age who reported suffering from upper or lower back pain in the last 6 months. Respondents were included if they reported that they had suffered from upper or lower back pain within the previous 6 months (in the categories currently suffering, in the last week, in the last fortnight, in the last month, in the last 2 to 3 mo, and in the last 4 to 6 mo). The episode of back pain did not have to be the respondent's first; respondents who indicated that this was a recurrent problem (ie, they had the same pain more than once) were also included. Exclusion criteria were age <18 years, occupation (advertising, market research, medical sector), people with no reported back pain in the 6 months before the survey date, or having suffered only other types of pain in the 6 months before the survey date.
Study Design
This cross-sectional self-report internet-based study was conducted in February 2009 by a commercial market research provider (The Digital Edge Pty Ltd, Sydney, Australia) using a permission-based online consumer panel. The online consumer panel comprises 70,000 individuals and is representative of the Australian adult population based on basic Australian Bureau of Statistics' sociodemographic profiles. Potential study participants (n=5638) were randomly selected from the panel and invited to participate in the study. The only restriction on sample pool selection was a maximum of 1 survey completed in the last 31 days. Of the 5638 potential participants who were invited into the study, 4418 declined to participate in the study, leaving 1220 participants who entered the initial screening phase of the study. All participants who entered the study (n=1220) received a nominal payment (AU$2.00) from the market research provider for completing this survey.
The survey comprised 5 screening questions, 8 demographic questions, and 16 questions relating to the respondents' back pain and its management. The questionnaire was administered in English only and no identifying data were collected. In accordance with the National Statement on Ethical Conduct in Human Research, prior ethical review was not undertaken for this activity. 15, 16 
Outcome Measures
The primary outcome measures were the prevalence, severity, health-related impact and duration of LBP, the extent and type of advice sought, and the first-line management options used. Secondary outcome measures focused on use of medicines and included the dose and duration of use of analgesics, the proportion of people with contraindications to selected analgesics, and the potential for drug-drug interactions.
Data Analyses
A minimum sample size of 1000 participants was sought to ensure a representative sample of back pain sufferers. Participants' responses were summarized and analysis was performed to identify significant differences between the groups. Height and weight data, reported by respondents, was used to estimate body mass index, which was then analyzed according to the current World Health Organization guidelines. Primary and secondary analyses were conducted among the respondents who reported only having LBP (n=570). All data analyses and statistics were performed using SPSS computer software (Version 15.0; SPSS Inc, Chicago, IL).
RESULTS
Respondent Characteristics
A total of 1220 participants were screened; 1001 who met the clinical inclusion criteria completed the survey and were included in the study results. There was an overlap in the type of back pain suffered in the previous 6 months, 570 (57%) respondents had LBP only, 96 (10%) had upper back pain only, and 335 (34%) had both. Baseline demographic data is based on the total number of respondents with any LBP in the previous 6 months (n=905; Table 1 ).
Severity and Duration of LBP
Self-reported pain severity was assessed using an 11point numerical pain scale (NPS), where 0=no pain and 10=the worst pain imaginable. The mean pain score among all LBP sufferers (n=570) was 5.17±2.03 and they reported being in pain for 13.6±11.1 days in the last month. There was a positive, statistically significant correlation between pain severity and the mean number of days suffered ( Fig. 1; P<0 .005). The duration (8.66 d vs. 14.34 d) and the severity of pain (mean pain score 4.77 vs. 5.23) were significantly lower in those who reported that this was their first occurrence of LBP (n=77) versus those who reported that it was a recurrent condition (n=493). wFor the purposes of this survey, social stratification was defined as follows: white collar=office-based labor, gray collar=working-class professions that do not involve significant manual labor, and blue collar=manual labor.
Care Seeking Behavior in Patients With LBP
Among those who received any advice about how to manage their LBP (331, 58%), the average number of sources was 1.87. This remained consistent regardless of whether the respondent was a first-time or a recurrent sufferer. The type of sources varied by first-time or recurrent pain (Table 2) ; the general practitioner (GP)/family doctor was the primary source of advice (29.9% and 42.6%, respectively) followed by a physiotherapist (14.3% and 14.6%, respectively), but more people with recurrent pain sought advice from specialists, pain specialists, and chiropractors. Regardless of whether it was a first-time or recurrent pain, there was an increasing trend to seek healthcare professional advice with increasing age and increasing pain severity.
The most frequent advice offered by any healthcare professional was exercise (which included stretching, walking, or swimming); 54% for first-time sufferers and 49% for recurrent sufferers (Table 3 ). GPs provided similar types of advice to other healthcare professionals, although with a higher emphasis on analgesics (predominantly for those with recurrent pain), rest, and heat treatment. There was little difference in the type of advice given to first-time and recurrent sufferers, with the exception that twice as many recurrent sufferers received advice to diet and/or lose weight (5.4% vs. 13.0%, P<0.05).
Initial Actions in Patients With LBP
Despite advice from healthcare professionals to exercise or stretch, only 106 respondents [19 (24.7%) of those with first-time back pain and 87 (17.8%) of those with recurrent pain] reported that their initial response to their LBP was to do additional stretching or exercise (Table 4 ). Among those with first-time back pain, 39.0% maintained their usual level of daily activity, whereas 32.5% were less active than normal. Among those with recurrent back pain, 31.8% maintained usual activities and 34.7% were less active than usual. Bed rest was not common, with the majority of those reporting that if they did take bed rest it was for less than 1 day (14.3% of first-time sufferers and 9.1% of recurrent sufferers), in keeping with the current guidelines recommending 2 days maximum bed rest.
Obesity and Weight Reduction
Over two-thirds (391, 68%) of respondents were selfreported to be either overweight or obese (based on the height and weight measurements they provided) and the majority had recurrent back problems. Yet, overall only 8% of the respondents reported that they were currently undertaking a weight reduction diet.
Initial Choice of Pain Relief for LBP
Among people seeking advice from any healthcare professional, pain relief was the second most frequent type of advice offered for first-time and recurrent LBP ( Table 3) . Pain relief was the most frequent initial reaction to back pain; 449 (79%) respondents reported using an analgesic, regardless of whether or not they had sought advice from a healthcare professional. Use of analgesic medication was higher among those with recurrent pain than those with first-time pain, regardless of whether it was an over-thecounter (OTC) preparation, a prescription, or a topical product ( Table 4 ). The mean pain scores at which the Values are number (%), more than one source of advice was sought in each group. respondents reported using these different forms of analgesia did not vary significantly between first-time and recurrent sufferers, although prescription products were used in those with the highest mean pain scores ( Fig. 2 ). Amongst all those who had used analgesic medicines, the choice of drug varied with pain severity ( Table 5 ). Paracetamol was predominantly the first choice of analgesic, followed by topical analgesic preparations ( Table 5 ). Among those who reported moderate to moderately severe pain (NPS score 3 to 7), around 25% reported the use of an NSAID first; whereas in people with severe pain (NPS score 8 to 10), there was a higher use of opioid analgesics or combination analgesic products (including fixed dose combinations or either paracetamol or ibuprofen plus codeine) as the first-line treatment.
Use of Simple Analgesics
During the course of their most recent back pain episode, use of OTC analgesics was high, with respondents showing use of a variety of different analgesic medicines. Paracetamol was used most frequently, irrespective of whether the respondent was suffering for the first time or had experienced the same pain before. Correlation of the choice of analgesic used with source of advice (who, if anyone, told you to use this medicine) revealed that for first-time sufferers paracetamol was the primary analgesic of choice and was predominantly used without seeking advice from anyone. Ibuprofen and combination products were second-line and third-line choices, irrespective of whether healthcare professional advice was sought or not ( Fig. 3) . For recurrent pain, there was an increase in the use of combination products at the expense of simple analgesics (paracetamol, ibuprofen), with this trend remaining regardless of whether healthcare professional advice was sought or not ( Fig. 3) .
Analysis of the reported dose of analgesic taken and the number of doses taken per day suggested the use of subtherapeutic analgesic dose regimens (Fig. 4) . Only a small number of respondents stated that they had used OTC ibuprofen (17%, 45) to relieve their back pain. However, among them, 6 (8%) reported that they also had a stomach ulcer and a further 3 (4%) reported that they were sensitive to aspirin. Analysis of concomitant use of NSAID analgesics, angiotensin converting enzyme inhibitors, and diuretics among people with LBP, showed that 10% of older respondents and 9% of those under the age of 65 years were potentially at risk of a significant 3-way drug interaction that can adversely affect renal function (triple whammy). The triple whammy interaction refers to the increased risk of acute renal failure in people who take NSAIDs while being treated with a diuretic and an angiotensin converting enzyme inhibitor or an angiotensin II receptor antagonist. 17, 18 
DISCUSSION
The demographic profile of our survey population was largely consistent with that found in a recent large European survey of chronic pain in terms of sex and age. 19 The point prevalence of LBP in our survey was similar to that published previously, 4 thus reconfirming that LBP remains a common problem in Australian adults. Importantly, our survey results (86.5% of respondents reported having recurrent LBP) are consistent with the prior published literature. 6, 7 The study included a large sample size and correlates with previous data suggesting a high level of internal validity of the results. However, the population used in this study presents some limitations, which restrict the ability to generalize the data to a wider population. The data provides a cross-sectional snapshot in time of consumers' self-reports of their condition and its management and may be subject to patient recall bias. The range of pain severities reported suggests that the population comprised a combination of acute, subacute, recurrent, and chronic LBP sufferers. No formal diagnosis or clinical investigation was undertaken and so the proportions cannot be verified.
Nevertheless, the questionnaire was structured to obtain data on management choices and therefore provides a strong indication of how individuals report that they manage their pain at a given point in time.
The literature suggests that over half (56%) of the people with LBP do not seek professional advice. [20] [21] [22] In our survey, we found that respondents were significantly more likely to seek advice from a healthcare professional if they had recurrent pain than if they had first-time pain (55% vs. 39%; P<0.05). Reluctance to seek advice from a healthcare professional at the first occurrence of acute LBP may therefore impact negatively on future recurrence rates.
Current best practices for the management of acute LBP emphasize the need to first rule out serious conditions or red flags and then provide reassurance to the patient that his/her condition is benign. 23 As part of that reassurance of recovery, bed rest should not be prescribed and patients should be advised to stay active and continue with their normal daily activities. People with acute LBP who are advised to rest in bed have a little more pain {standardized mean difference (SMD) 0.22 [95% confidence interval (CI): 0.02-0.41]} and a little less functional recovery [SMD 0.29 (95% CI: 0.05-0.45)] than those advised to stay active. 24 In the present study, 26% of respondents with first-time LBP reported that they took bed rest; with the majority of these taking bed rest for less than 1 day. By contrast, significantly fewer (15%) respondents with recurrent LBP took any bed rest. This can be interpreted in 2 ways; either that when the pain recurs, the patient is more likely to seek healthcare professional advice and follow that advice or that when the patient first experiences pain, his or her reluctance to seek advice means missing out on a vital aspect of self-care. Either way it is important to ensure that patients consider the consequences of not seeking advice. Advice to exercise was the most frequent type of healthcare professional advice received by respondents in our survey. Specific exercise therapy has not been part of previous guidelines for the management of acute LBP. However, the literature provides support for exercise therapy in chronic LBP. [25] [26] [27] [28] [29] Guidelines now recommend that patients be offered a structured exercise programme tailored to suit their needs as part of the early management of chronic LBP. 12, 13, 30 Such exercise programs may include aerobic activity, movement instruction, muscle strengthening, postural control, and stretching. Curiously, our survey found that a higher proportion of respondents with firsttime LBP carried out additional stretching or other exercises than did those with recurrent pain (25% vs. 18%). Additionally, GPs were more likely to have recommended exercise to people with first-time LBP than to those with recurrent LBP (59% vs. 39%). These findings suggest a need to ensure that GPs and consumers are aware of guidelines with respect to exercise therapy, what to undertake and when best to undertake it.
An escalating epidemic of obesity is affecting many countries in the world, of which Australia is one. Available Australian data indicate that 52% women and 67% of men are overweight or obese. 31 Our study sample was consistent with these data. Despite both being common public health problems, evidence of a direct causative link between obesity and LBP is not strong. Data compiled by Mirtz et al 32 combined with that from more recent studies 33, 34 provide some evidence supporting that abdominal obesity in females is a risk factor for LBP. Irrespective of the lack of data supporting a direct association, advice to reduce weight is warranted, particularly among those patients with a recurrent or chronic problem. 35 In the present study, overall only 10% of people recalled receiving advice to lose weight from a healthcare professional. More respondents with recurrent pain reported having received such advice than did respondents with first-time back pain (13% vs. 5%), indicating that healthcare professionals may be more likely to address other issues when LBP recurs rather than at the first presentation. Nevertheless, a very small proportion of respondents (8%) were currently undertaking any weight loss activity highlighting the need for the provision of ongoing advice and support to these patients.
Although guidelines for acute LBP recommend paracetamol as the first-line analgesic therapy, 1, 23 there is no clear consensus on this when it comes to managing chronic or recurrent LBP. [12] [13] [14] Nevertheless, all guidelines advocate the use of specific pharmacologic interventions to relieve LBP. In concert with this, use of analgesic medication was prevalent in this study; 61% of respondents with reported first-time pain and 82% of those reporting recurrent pain indicated that they had used some form of analgesic medication to help manage their most recent episode of LBP.
With respect to pharmacologic intervention of acute back pain, the current guidelines recommend the use of paracetamol, administered regularly, for mild to moderate pain, with NSAIDs being used only if paracetamol provides insufficient pain relief and the patient has no contraindications to their use. 23 These guidelines follow the principles of the quality use of medicines. In the present study, the majority of people reported using OTC paracetamol to manage their back pain. OTC ibuprofen was used less frequently, followed by combination products. Our study design was limited in that it focused only on the most recent episode of LBP and therefore did not probe further back into the history of those respondents who reported recurrent LBP. Although this aided in reducing recall bias, it prevented us from determining whether paracetamol had already been trialed. Two-thirds (66%, 293/445) of the respondents who reported using pain relief had a pain score of 5 or more and 258 (88%) of them had recurrent LBP. Thus, although a proportion of these respondents may have followed the above guidelines, our finding that only 50% to 64% were using paracetamol is still somewhat low.
Analgesic medication was considered to be the best method of pain relief by 65% of respondents with chronic pain of any type in a German primary care survey. 36 Four out of 5 (82%) of our respondents with recurrent pain reported taking some form of analgesia. Recent survey results from Europe indicate a high use of prescription and nonprescription analgesics among patients with chronic pain. In that survey, 52% of respondents were currently taking a prescription pain reliever; the most common being an NSAID (44%), weak opioid analgesics (23%), and paracetamol (18%). Although the dataset was not restricted to chronic LBP, the prevalent use of NSAIDs and weak opioids reflects the current advice given in the European guidelines for that condition. 12 In contrast, paracetamol was still the predominant analgesic of choice in our recurrent sufferers, although its use was lower than for first-time suffers at the expense of combination products. NSAID use was not high in either the first-time or the recurrent sufferers.
Analysis of information relating to dose and duration of use of analgesic (irrespective of whether the respondent had first-time or recurrent pain) showed that there was substantial subtherapeutic use of paracetamol. The majority of respondents who reported that they took paracetamol were not taking adequate doses. This has implications regarding the quality use of medicines. Subtherapeutic dosing needs to be addressed to ensure effective paracetamol doses have been adequately trialed before the patient is escalated to an alternative analgesic. It has previously been shown that encouraging regular use of paracetamol in acute LBP has a positive impact on outcome. 8 However, when used to manage musculoskeletal pain paracetamol may be perceived as being ineffective when insufficient doses or irregular dosing schedules are used. Paracetamol has a short half-life, necessitating regular (4 to 6 hourly) dosing. Under-dosing, and a resultant inadequate therapeutic response, has also been demonstrated in other mild to moderate pain states for which paracetamol is recommended first line, such as osteoarthritis. 37, 38 It is possible that the inconvenience of needing to take 2 tablets 4 times daily for standard paracetamol formulations may contribute to the failure of individuals to take the maximum recommended dose. Healthcare professionals have an important role to play in questioning the patient about adherence and offering strategies to improve it.
OTC analgesics are generally considered safe and are well tolerated if taken in the right doses and the labeled instructions are carefully followed. Based on its labeled warnings, contraindications, and precautions, OTC paracetamol is suitable for use by a large proportion of the general population without the need to seek medical advice (98% vs. 77% for ibuprofen and 83% for aspirin). 39 Current stomach ulcer is a contraindication to NSAID use, yet 6 (35%) of the 20 study respondents who reported that they had a current stomach ulcer were taking OTC ibuprofen. In addition, 9% of people <65 years of age and 10% of those 65 years or more were concomitantly taking OTC ibuprofen and antihypertensive medications, putting them at increased risk of therapeutic failure or, at worst, acute renal failure.
Consideration needs to be given to how best to educate consumers as to the most suitable analgesic for their particular circumstance, including an increased appreciation of the contraindications, warning, precautions and potential drug-drug interactions associated with different analgesics. Where healthcare professional advice is available to consumers at the point of purchase, such as in the community pharmacy setting, it is appropriate to ask simple questions about the patients' age, any other medications they are taking, and any other medical conditions they have. A simple protocol (age-interactionsmedications) to quickly evaluate a customer's individual analgesic suitability and ensure that he or she receives the most appropriate analgesic for his or her condition has previously been proposed for use in the pharmacy setting. 39 However, only 2% of respondents in the study had sought advice from a pharmacist regarding management of their back pain. Additional means of conveying suitability information to consumers may be warranted, particularly outside the pharmacy setting.
CONCLUSIONS
The study has shown that the choices of patients regarding management of their pain and disability do not always follow current LBP guideline recommendations. Over half did not seek any professional advice. Curiously, patients were more likely to try stretching or extra exercise for acute back pain than chronic or recurrent pain, despite there being stronger evidence for exercise in chronic pain. A high proportion of patients were overweight or obese (68%), which may contribute to disability, yet few (8%) received advice to lose weight.
The good news is that few patients were advised to rest in bed and very few rested for longer than 2 days. In contrast, many patients were taking OTC medications (about half on advice of a health professional). Paracetamol was frequently used in suboptimal doses, whereas a small number of patients were taking an NSAID despite having contraindications to taking them. Society benefits from consumers who are better informed about healthcare and therefore more able to exercise self-reliance. However, it is important to ensure that self-reliance is underpinned by adequate education and adherence to best practice guidelines.
